We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Name | Symbol | Market | Type |
|---|---|---|---|
| BioNTech SE | NASDAQ:BNTX | NASDAQ | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.18 | 1.33% | 90.00 | 88.17 | 90.00 | 90.66 | 86.36 | 86.77 | 426,984 | 01:00:00 |
From May 2021 to May 2024
By Cecilia Butini
Siemens AG said Wednesday that it is expanding its cooperation with German pharmaceutical company BioNTech SE on production capacity for Covid-19 vaccines.
"Within this cooperation, Siemens will provide the latest automation and digitalization technologies for BioNTech production sites, such as design, simulation, and engineering software as well as process control technology," the German company said.
BioNTech previously said that it would establish new production sites for vaccine production worldwide, starting with a new production facility in Singapore. The pharmaceutical company has also converted an existing plant in Marburg, Germany into a vaccine production facility using support from Siemens, Siemens said.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
June 23, 2021 10:20 ET (14:20 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year BioNTech Chart |
1 Month BioNTech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
